Cargando…
A novel non-sulphamoylated 2-methoxyestradiol derivative causes detachment of breast cancer cells by rapid disassembly of focal adhesions
BACKGROUND: 2-Methoxyestradiol (2ME2) is an estradiol metabolite with well documented antiproliferative properties in many cancer cell lines. However, it is rapidly metabolised in vivo which limits its clinical application. Therefore, more stable derivatives with potentially improved clinical featur...
Autores principales: | Botes, Mandie, Jurgens, Tamarin, Riahi, Zohreh, Visagie, Michelle, Janse van Vuuren, Rustelle, Joubert, Anna Margaretha, van den Bout, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245879/ https://www.ncbi.nlm.nih.gov/pubmed/30479567 http://dx.doi.org/10.1186/s12935-018-0688-7 |
Ejemplares similares
-
Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2019) -
Correction to: Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2020) -
A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell lines
por: Visagie, Michelle Helen, et al.
Publicado: (2015) -
A bis-sulphamoylated estradiol derivative induces ROS-dependent cell cycle abnormalities and subsequent apoptosis
por: Visagie, Michelle Helen, et al.
Publicado: (2017) -
Sulphamoylated 2-Methoxyestradiol Analogues Induce Apoptosis in Adenocarcinoma Cell Lines
por: Visagie, Michelle, et al.
Publicado: (2013)